Cargando…
Can magnetic resonance spectroscopy differentiate malignant and benign causes of lymphadenopathy? An in-vitro approach
Lymphadenopathy continues to be a common problem to radiologists and treating physicians because of the difficulty in confidently categorizing a node as being benign or malignant using standard diagnostic techniques. The goal of our research was to assess whether magnetic resonance (MR) spectroscopy...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549694/ https://www.ncbi.nlm.nih.gov/pubmed/28792506 http://dx.doi.org/10.1371/journal.pone.0182169 |
_version_ | 1783256012717817856 |
---|---|
author | Buré, Lionel Boucher, Louis-Martin Blumenkrantz, Miriam Schob, Stefan Lafaye de Micheaux, Pierre Reinhold, Caroline Gallix, Benoit |
author_facet | Buré, Lionel Boucher, Louis-Martin Blumenkrantz, Miriam Schob, Stefan Lafaye de Micheaux, Pierre Reinhold, Caroline Gallix, Benoit |
author_sort | Buré, Lionel |
collection | PubMed |
description | Lymphadenopathy continues to be a common problem to radiologists and treating physicians because of the difficulty in confidently categorizing a node as being benign or malignant using standard diagnostic techniques. The goal of our research was to assess whether magnetic resonance (MR) spectroscopy contains the necessary information to allow differentiation of benign from malignant lymph nodes in an in-vitro approach using a modern pattern recognition method. Tissue samples from a tissue bank were analyzed on a nuclear magnetic resonance (NMR) spectrometer. A total of 69 samples were studied. The samples included a wide variety of malignant and benign etiologies. Using 45 samples, we initially created a model which was able to predict if a certain spectrum originates from benign or malignant lymph nodes using a pattern-recognition technique which takes into account the entire magnetic spectrum rather than single peaks alone. The remaining 24 samples were blindly loaded in the model to assess its performance. We obtained an excellent accuracy in differentiating benign and malignant lymphadenopathy using the model. It correctly differentiated as malignant or benign, in a blinded fashion, all of the malignant samples (13 of 13) and 10 out of the 11 benign samples. We thus showed that magnetic spectroscopy is able to differentiate benign from malignant causes of lymphadenopathy. Additional experiments were performed to verify that the differentiating abilities of our model were not due to differential tissue decay in between benign and malignant tissues. If future experiments demonstrate that a similar approach could be executed with standard MR imaging, this technique could be useful as a problem-solving tool when assessing lymphadenopathy in general. Alternatively, our in-vitro technique could also be useful to pathologists faced with indeterminate pathologies of the lymph nodes after validating our results with a larger sample size. |
format | Online Article Text |
id | pubmed-5549694 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-55496942017-08-12 Can magnetic resonance spectroscopy differentiate malignant and benign causes of lymphadenopathy? An in-vitro approach Buré, Lionel Boucher, Louis-Martin Blumenkrantz, Miriam Schob, Stefan Lafaye de Micheaux, Pierre Reinhold, Caroline Gallix, Benoit PLoS One Research Article Lymphadenopathy continues to be a common problem to radiologists and treating physicians because of the difficulty in confidently categorizing a node as being benign or malignant using standard diagnostic techniques. The goal of our research was to assess whether magnetic resonance (MR) spectroscopy contains the necessary information to allow differentiation of benign from malignant lymph nodes in an in-vitro approach using a modern pattern recognition method. Tissue samples from a tissue bank were analyzed on a nuclear magnetic resonance (NMR) spectrometer. A total of 69 samples were studied. The samples included a wide variety of malignant and benign etiologies. Using 45 samples, we initially created a model which was able to predict if a certain spectrum originates from benign or malignant lymph nodes using a pattern-recognition technique which takes into account the entire magnetic spectrum rather than single peaks alone. The remaining 24 samples were blindly loaded in the model to assess its performance. We obtained an excellent accuracy in differentiating benign and malignant lymphadenopathy using the model. It correctly differentiated as malignant or benign, in a blinded fashion, all of the malignant samples (13 of 13) and 10 out of the 11 benign samples. We thus showed that magnetic spectroscopy is able to differentiate benign from malignant causes of lymphadenopathy. Additional experiments were performed to verify that the differentiating abilities of our model were not due to differential tissue decay in between benign and malignant tissues. If future experiments demonstrate that a similar approach could be executed with standard MR imaging, this technique could be useful as a problem-solving tool when assessing lymphadenopathy in general. Alternatively, our in-vitro technique could also be useful to pathologists faced with indeterminate pathologies of the lymph nodes after validating our results with a larger sample size. Public Library of Science 2017-08-08 /pmc/articles/PMC5549694/ /pubmed/28792506 http://dx.doi.org/10.1371/journal.pone.0182169 Text en © 2017 Buré et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Buré, Lionel Boucher, Louis-Martin Blumenkrantz, Miriam Schob, Stefan Lafaye de Micheaux, Pierre Reinhold, Caroline Gallix, Benoit Can magnetic resonance spectroscopy differentiate malignant and benign causes of lymphadenopathy? An in-vitro approach |
title | Can magnetic resonance spectroscopy differentiate malignant and benign causes of lymphadenopathy? An in-vitro approach |
title_full | Can magnetic resonance spectroscopy differentiate malignant and benign causes of lymphadenopathy? An in-vitro approach |
title_fullStr | Can magnetic resonance spectroscopy differentiate malignant and benign causes of lymphadenopathy? An in-vitro approach |
title_full_unstemmed | Can magnetic resonance spectroscopy differentiate malignant and benign causes of lymphadenopathy? An in-vitro approach |
title_short | Can magnetic resonance spectroscopy differentiate malignant and benign causes of lymphadenopathy? An in-vitro approach |
title_sort | can magnetic resonance spectroscopy differentiate malignant and benign causes of lymphadenopathy? an in-vitro approach |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549694/ https://www.ncbi.nlm.nih.gov/pubmed/28792506 http://dx.doi.org/10.1371/journal.pone.0182169 |
work_keys_str_mv | AT burelionel canmagneticresonancespectroscopydifferentiatemalignantandbenigncausesoflymphadenopathyaninvitroapproach AT boucherlouismartin canmagneticresonancespectroscopydifferentiatemalignantandbenigncausesoflymphadenopathyaninvitroapproach AT blumenkrantzmiriam canmagneticresonancespectroscopydifferentiatemalignantandbenigncausesoflymphadenopathyaninvitroapproach AT schobstefan canmagneticresonancespectroscopydifferentiatemalignantandbenigncausesoflymphadenopathyaninvitroapproach AT lafayedemicheauxpierre canmagneticresonancespectroscopydifferentiatemalignantandbenigncausesoflymphadenopathyaninvitroapproach AT reinholdcaroline canmagneticresonancespectroscopydifferentiatemalignantandbenigncausesoflymphadenopathyaninvitroapproach AT gallixbenoit canmagneticresonancespectroscopydifferentiatemalignantandbenigncausesoflymphadenopathyaninvitroapproach |